2B0973P: LIDOCAINE HYDROCHLORIDE AND DEXT.
LIDOCAINE HYDROCHLORIDE AND DEXT. Key specifications include administration: INTRAVENOUS INFUSION, primary_container_type: BAG, PLASTIC, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 18, primary_container_content_quantity: 500.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-194-7265, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS INFUSION |
| primary_container_type | BAG, PLASTIC |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 18 |
| primary_container_content_quantity | 500.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION 500ML 18S |
| NSN | 6505-01-194-7265 |
| ADMINISTRATION | INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE HYDROCHLORIDE AND DEXTROSE INJECTION 500ML 18S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 18 |
No substitute or cross-reference records for this part.